Literature DB >> 23717741

A caval homograft for Budd-Chiari syndrome due to inferior vena cava obstruction.

Andrea Mancuso1, Luigi Martinelli, Luciano De Carlis, Antonio Gaetano Rampoldi, Giovanni Magenta, Aldo Cannata, Luca Saverio Belli.   

Abstract

Transjugular intrahepatic portosystemic shunt (TIPS) is the standard treatment of Budd-Chiari syndrome (BCS) non responsive to medical therapy. However, patients with inferior vena cava (IVC) obstruction proximal to the atrium do not benefit from TIPS and a surgical approach is mandatory. We report the case of BCS due to intrapericardial IVC obstruction. We describe a novel surgical approach using a fresh caval homograft. An attempt to balloon dilatation of the IVC obstruction was complicated by right atrial disruption with tamponade and ventricular fibrillation. Lately, the patient successfully underwent a reconstruction of the cavo-atrial continuity by the interposition of a fresh caval homograft, a novel surgical approach never described before for BCS. Further follow-up revealed progressive reduction and resolution of ascites, and overall clinical improvement. IVC obstruction near to the atrium can be surgically approached with a new technique consisting in inferior vena cava resection and replacement with a caval homograft.

Entities:  

Keywords:  Budd-Chiari syndrome; Inferior vena cava; Liver transplantation; Occlusion; Surgery

Year:  2013        PMID: 23717741      PMCID: PMC3664288          DOI: 10.4254/wjh.v5.i5.292

Source DB:  PubMed          Journal:  World J Hepatol


  15 in total

1.  Budd-Chiari syndrome revisited: 38 years' experience with surgical portal decompression.

Authors:  Marshall J Orloff; Jon I Isenberg; Henry O Wheeler; Pat O Daily; Barbara Girard
Journal:  J Gastrointest Surg       Date:  2011-11-08       Impact factor: 3.452

Review 2.  Management of hepatic vascular diseases.

Authors:  Aurélie Plessier; Pierre-Emmanuel Rautou; Dominique-Charles Valla
Journal:  J Hepatol       Date:  2012       Impact factor: 25.083

3.  Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome.

Authors:  C E Eapen; D Velissaris; M Heydtmann; B Gunson; S Olliff; E Elias
Journal:  Gut       Date:  2005-09-20       Impact factor: 23.059

4.  Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres.

Authors:  Gilles Mentha; Emiliano Giostra; Pietro E Majno; Wolf O Bechstein; Peter Neuhaus; John O'Grady; Raaj K Praseedom; Andrew K Burroughs; Yves P Le Treut; Preben Kirkegaard; Xavier Rogiers; Bo-Goran Ericzon; Krister Hockerstedt; René Adam; Juergen Klempnauer
Journal:  J Hepatol       Date:  2005-12-27       Impact factor: 25.083

5.  Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting.

Authors:  N C Fisher; I McCafferty; M Dolapci; M Wali; J A Buckels; S P Olliff; E Elias
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

6.  Superior mesenteric vein-caval-right atrium Y shunt for treatment of Budd-Chiari syndrome with obstruction to the inferior vena cava and the hepatic veins--a study of 62 patients.

Authors:  Yewei Zhang; Hewei Zhao; Dongliang Yan; Huanzhou Xue; Wan Yee Lau
Journal:  J Surg Res       Date:  2011-03-21       Impact factor: 2.192

7.  TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients.

Authors:  Juan Carlos Garcia-Pagán; Mathis Heydtmann; Sebastian Raffa; Aurélie Plessier; Sarwa Murad; Federica Fabris; Giovanni Vizzini; Juan Gonzales Abraldes; Simon Olliff; Antonio Nicolini; Angelo Luca; Massimo Primignani; Harry L A Janssen; Dominique Valla; Elwyn Elias; Jaume Bosch
Journal:  Gastroenterology       Date:  2008-05-21       Impact factor: 22.682

8.  TIPS for acute and chronic Budd-Chiari syndrome: a single-centre experience.

Authors:  Andrea Mancuso; Konrad Fung; Maria Mela; John Tibballs; Anthony Watkinson; Andrew K Burroughs; David Patch
Journal:  J Hepatol       Date:  2003-06       Impact factor: 25.083

9.  Etiology, management, and outcome of the Budd-Chiari syndrome.

Authors:  Sarwa Darwish Murad; Aurelie Plessier; Manuel Hernandez-Guerra; Federica Fabris; Chundamannil E Eapen; Matthias J Bahr; Jonel Trebicka; Isabelle Morard; Luc Lasser; Joerg Heller; Antoine Hadengue; Philippe Langlet; Helena Miranda; Massimo Primignani; Elwyn Elias; Frank W Leebeek; Frits R Rosendaal; Juan-Carlos Garcia-Pagan; Dominique C Valla; Harry L A Janssen
Journal:  Ann Intern Med       Date:  2009-08-04       Impact factor: 25.391

10.  Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients.

Authors:  B Ringe; H Lang; K J Oldhafer; M Gebel; P Flemming; A Georgii; H G Borst; R Pichlmayr
Journal:  Hepatology       Date:  1995-05       Impact factor: 17.425

View more
  3 in total

1.  Timing of Transjugular Intrahepatic Portosystemic Shunt for Budd-Chiari Syndrome: An Italian Hepatologist's Perspective.

Authors:  Andrea Mancuso
Journal:  J Transl Int Med       Date:  2017-12-29

2.  Replacement of Vena Cava up to the Right Atrium during Living Donor Liver Transplantation for Echinococcus alveolaris.

Authors:  Fahri Yetişir; S Murad Dogan; Ruslan Mamedov; Cuneyt Kayaalp; Sezayi Yilmaz
Journal:  Case Rep Transplant       Date:  2014-11-20

3.  Living-donor liver transplantation in Budd-Chiari syndrome with inferior vena cava complete thrombosis: A case report and review of the literature.

Authors:  Vinicius Rocha-Santos; Daniel Reis Waisberg; Rafael Soares Pinheiro; Lucas Souto Nacif; Rubens Macedo Arantes; Liliana Ducatti; Rodrigo Bronze Martino; Luciana Bertocco Haddad; Flavio Henrique Galvao; Wellington Andraus; Luiz Augusto Carneiro-D'Alburquerque
Journal:  World J Hepatol       Date:  2021-01-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.